Missing Data in Clinical Studies

被引：12

作者：

Chowdhry, Amit K. ^{[1
]}

Gondi, Vinai ^{[2
,3
]}

Pugh, Stephanie L. ^{[4
]}

机构：

[1] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA

[2] Northwestern Med Canc Ctr Warrenville, Warrenville, IL USA

[3] Northwestern Med Proton Ctr, Warrenville, IL USA

[4] Amer Coll Radiol, NRG Oncol Stat & Data Management Ctr, Philadelphia, PA USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 110卷 / 05期

关键词：

HIPPOCAMPAL AVOIDANCE;

D O I：

10.1016/j.ijrobp.2021.02.042

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1267 / 1271

页数：5

共 14 条

[1]

[Anonymous], 2019, STAT ANAL MISSING DA

[2] Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) [J].

Armstrong, T. S. ;

Mendoza, T. ;

Gring, I. ;

Coco, C. ;

Cohen, M. Z. ;

Eriksen, L. ;

Hsu, Ming-Ann ;

Gilbert, M. R. ;

Cleeland, C. .

JOURNAL OF NEURO-ONCOLOGY, 2006, 80 (01) :27-+

[3]

Armstrong T, 2019, NEURO-ONCOLOGY, V21, P24

[4] The Impact of Symptom Interference Using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on Prediction of Recurrence in Primary Brain Tumor Patients [J].

Armstrong, Terri S. ;

Vera-Bolanos, Elizabeth ;

Gning, Ibrahima ;

Acquaye, Alvina ;

Gilbert, Mark R. ;

Cleeland, Charles ;

Mendoza, Tito .

CANCER, 2011, 117 (14) :3222-3228

[5] Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001 [J].

Brown, Paul D. ;

Gondi, Vinai ;

Pugh, Stephanie ;

Tome, Wolfgang A. ;

Wefel, Jeffrey S. ;

Armstrong, Terri S. ;

Bovi, Joseph A. ;

Robinson, Cliff ;

Konski, Andre ;

Khuntia, Deepak ;

Grosshans, David ;

Benzinger, Tammie L. S. ;

Bruner, Deborah ;

Gilbert, Mark R. ;

Roberge, David ;

Kundapur, Vijayananda ;

Devisetty, Kiran ;

Shah, Sunjay ;

Usuki, Kenneth ;

Anderson, Bethany Marie ;

Stea, Baldassarre ;

Yoon, Harold ;

Li, Jing ;

Laack, Nadia N. ;

Kruser, Tim J. ;

Chmura, Steven J. ;

Shi, Wenyin ;

Deshmukh, Snehal ;

Mehta, Minesh P. ;

Kachnic, Lisa A. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (10) :1019-+

[6]

Coens C, 2020, LANCET ONCOL, V21, pE83, DOI 10.1016/S1470-2045(19)30790-9

[7] Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide [J].

Cro, Suzie ;

Morris, Tim P. ;

Kenward, Michael G. ;

Carpenter, James R. .

STATISTICS IN MEDICINE, 2020, 39 (21) :2815-2842

[8] When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts [J].

Jakobsen, Janus Christian ;

Gluud, Christian ;

Wetterslev, Jorn ;

Winkel, Per .

BMC MEDICAL RESEARCH METHODOLOGY, 2017, 17

[9] The Prevention and Treatment of Missing Data in Clinical Trials [J].

Little, Roderick J. ;

D'Agostino, Ralph ;

Cohen, Michael L. ;

Dickersin, Kay ;

Emerson, Scott S. ;

Farrar, John T. ;

Frangakis, Constantine ;

Hogan, Joseph W. ;

Molenberghs, Geert ;

Murphy, Susan A. ;

Neaton, James D. ;

Rotnitzky, Andrea ;

Scharfstein, Daniel ;

Shih, Weichung J. ;

Siegel, Jay P. ;

Stern, Hal .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14) :1355-1360

[10] The proportion of missing data should not be used to guide decisions on multiple imputation [J].

Madley-Dowd, Paul ;

Hughes, Rachael ;

Tilling, Kate ;

Heron, Jon .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2019, 110 :63-73

← 1 2 →